Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trial
Critical Path Institute Continues to Expand Stephen Joel Coons, PhD, Joins as Director of the newly formed Patient-Reported Outcomes Consortium
C-Path Researchers Crack Diseases Through Math, Info Sharing This week, Inside Tucson Business debuts a new monthly feature which profiles the work of young scientists. The idea is to showcas
C-Path is No. 7 in Reader’s Digest List of 18 Big Ideas to Fix Healthcare Now The November 2008 issue of Reader’s Digest lists 18 big ideas to fix healthcare now and the Critical Path Insitute is listed
C-Path and Ventana Medical Systems to Collaborate The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat
C-Path Receives $675,000.00 Award for FDA Collaboration The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh
C-Path Forms Drug Testing Pact The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companie
